Sex differences in the vulnerability to drug abuse: a review of preclinical studies.
Clinical and preclinical findings indicate that males and females differ on several aspects of drug reinforcement. Females are more vulnerable than males during transition periods of drug use that are characteristic of drug addiction and relapse. Females are also more sensitive than males to the reinforcing effects of stimulants. It has been suggested that ovarian hormones contribute to the mechanisms of action underlying these sex differences. This review examines the preclinical literature on sex differences and ovarian hormonal influences on drug self-administration in animals. It summarizes the findings on the effects of these variables during different phases of drug addiction. Possible differences in the mechanisms of action of drugs of abuse due to interactions with sex differences or ovarian hormonal factors are considered. The animal literature on sex differences in drug abuse treatment effectiveness is also discussed.
Roth
Megan E
ME
Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA. roth0180@umn.edu
Cosgrove
Kelly P
KP
Carroll
Marilyn E
ME
D000818:Animals; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D012054:Reinforcement, Psychology; D012646:Self Administration; D012727:Sex Characteristics; D019966:Substance-Related Disorders / Q000503:physiopathology* / Q000523:psychology* / Q000628:therapy
D004967:Estrogens